Literature DB >> 14732779

Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes.

Tracy S Wang1, Sanford Dubner, Laura A Sznyter, Keith S Heller.   

Abstract

OBJECTIVE: To determine the incidence of clinically positive lateral cervical nodes at presentation and after initial treatment in patients with well-differentiated thyroid cancer.
DESIGN: Retrospective chart review.
SETTING: University-affiliated teaching hospitals. PATIENTS: A total of 508 patients who underwent a thyroidectomy as part of their initial treatment for well-differentiated thyroid carcinoma between January 1978 and December 1999. Neck dissections were performed only for clinically palpable cervical nodes. MAIN OUTCOME MEASURES: Recurrence in the neck and survival.
RESULTS: Forty-four patients (9%) had palpable lateral cervical lymph nodes at the time of surgery. All 31 patients younger than 45 years presenting with palpable positive nodes are alive and free of disease; 4 of 13 patients 45 years or older have died of thyroid cancer. Only 16 (3%) of 464 patients who did not undergo initial neck dissection had recurrence in lateral cervical nodes. Recurrence is more likely when the initial tumor is larger than 4 cm. In 216 patients younger than 45 years, there were 5 (2%) recurrences in lateral cervical nodes; these patients remain alive and free of disease. In 248 patients 45 years or older, there were 11 (4%) with recurrent disease in the lateral neck; 4 of these patients have died of thyroid cancer.
CONCLUSIONS: An aggressive approach to detecting and treating occult lateral cervical nodes by techniques such as jugular node sampling, sentinel node biopsy, or image-guided needle biopsy is not necessary in most patients. Attempts to detect and remove occult lateral cervical lymph node metastases might be considered in older patients with large primary tumors.

Entities:  

Mesh:

Year:  2004        PMID: 14732779     DOI: 10.1001/archotol.130.1.110

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  18 in total

1.  A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.

Authors:  Zhong Ying Rui; Yang Liu; Wei Zheng; Xuan Wang; Zhao Wei Meng; Jian Tan; Ning Li; Qiang Jia
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.

Authors:  Parameswaran Rajeev; Sohail Ahmed; Tarek M Ezzat; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2012-12-30       Impact factor: 3.445

4.  Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia.

Authors:  Bogdan Galusca; Jean Marc Dumollard; Sandrine Lassandre; Alain Niveleau; Jean Michel Prades; Bruno Estour; Michel Peoc'h
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

5.  Patient Report of Recurrent and Persistent Thyroid Cancer.

Authors:  Maria Papaleontiou; Josh M Evron; Nazanene H Esfandiari; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Francis Worden; Megan R Haymart
Journal:  Thyroid       Date:  2020-04-16       Impact factor: 6.568

6.  Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.

Authors:  I Christakis; S Dimas; I D Kafetzis; N Roukounakis
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

7.  Pathological characteristics and clinical perspectives of papillary thyroid cancer: study of 714 patients.

Authors:  Davor Džepina; Krešo Zurak; Vlado Petric; Hrvoje Čupić
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

8.  Reoperative experience with papillary thyroid cancer.

Authors:  Edwin O Onkendi; Travis J McKenzie; Melanie L Richards; David R Farley; Geoffrey B Thompson; Jan L Kasperbauer; Ian D Hay; Clive S Grant
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

9.  Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis.

Authors:  Chung-Jie Cao; Cheng-Yun Dou; Jiayan Lian; Zhao-Sheng Luan; Wen Zhou; Wenlin Xie; Li Chen; Kehua Zhou; Hong Lai
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

10.  The potential role of carbon nanoparticles-assisted biopsy for sentinel lymph nodes of incidental thyroid carcinoma.

Authors:  Chaojie Zhang; Xinying Li; Zhigong Zhang; Shanshan Lei; Peizhi Fan; Qiang Xiao
Journal:  Gland Surg       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.